s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
3
Duncan Jason: Initial statement of beneficial ownership of securities
Filed
Tuesday, December 12, 2023
Period
Dec 11, 2023
Accession number
0001610717-23-000397
Documents
form3.xml
3
POWER OF ATTORNEY
EX-24.1
On sec.gov
Filing index
All files
Complete submission text
SGML header